Vimab Group Valuation
Is VIMAB undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 0/6
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for VIMAB?
Other financial metrics that can be useful for relative valuation.
|What is VIMAB's n/a Ratio?|
Price to Book Ratio vs Peers
How does VIMAB's PB Ratio compare to its peers?
|Company||PB||Estimated Growth||Market Cap|
HIFA B Hifab Group AB (publ.)
PENG B Projektengagemang Sweden
EURO Eurocon Consulting
ME Modern Ekonomi Sverige Holding
VIMAB Vimab Group
Price-To-Book vs Peers: Insufficient data to calculate VIMAB's Price-To-Book Ratio vs. peers for valuation analysis.
Price to Earnings Ratio vs Industry
How does VIMAB's PE Ratio compare vs other companies in the SE Professional Services Industry?
Price to Book Ratio vs Fair Ratio
What is VIMAB's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PB Ratio||n/a|
|Fair PB Ratio||n/a|
Price-To-Book vs Fair Ratio: Insufficient data to calculate VIMAB's Price-To-Book Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of VIMAB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate VIMAB's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate VIMAB's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
- Take a look at our analysis of VIMAB's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through Vimab Group regulatory filings.
- Potentially undervalued companies in the Commercial Services industry.